Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure,…
Browsing: The Lancet
eLife is an open-access scientific journal that focuses on the publication of significant research across the life and biomedical sciences. Launched in 2012, eLife was initially funded by three major research funders: the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust, with a mission to improve the way scientific findings are reviewed and shared. The journal employs a unique peer-review process that emphasizes constructive dialogue between authors and reviewers, which aims to ensure that published research is of high quality and is robustly validated. eLife has set itself apart by being not just a platform for publishing research but also an advocate for reform in the scientific communication landscape, promoting transparency, reproducibility, and accessibility in science.
Researchers are testing a new single-dose pill that could make treating gonorrhea easier as antibiotic…
A major new three-paper Series in The Lancet shows that ultra-processed foods are pushing aside…
High-dose semaglutide drives greater weight loss. Safety remains favorable but needs further study. A weekly…
Obesity is set to reach catastrophic levels by 2050, affecting over half the global adult…
The 2024 Lancet Commission report identifies vision loss and high cholesterol as new risk factors…
About 15% of individuals stopping antidepressants face discontinuation symptoms, with severe cases in 3%. This…
Boosting the Efficacy of Emergency Contraception According to a randomized controlled trial recently published in…
The Lancet Public Health: Hearing aids may protect against a higher risk of dementia associated…
A Lancet study finds that natural immunity against severe COVID-19 is strong and long-lasting for…
Research suggests that stricter COVID-19 measures are associated with negative mental health effects and a…
A study finds young males at higher risk from alcohol, while adults over 40 may…
Vaccines significantly reduced global COVID-19 deaths, but unmet vaccination targets highlight the need for better…
Study of 1,192 participants hospitalized with COVID-19 in Wuhan, China, between January 7th and May…
The Ad5-nCoV vaccine, developed in China, is 57.5% effective against symptomatic COVID-19 infection and 91.7%…
Study includes more than 2,700 healthcare workers in Delhi, India, who were symptomatic and underwent…
Study of 621 people in the UK with mild COVID-19 infections found that people who…
First global estimates of the impact of the COVID-19 pandemic on mental health in 2020…